Locations:
Search
BACE1 inhibitor reduces cancer progression in models of glioblastoma
Multidisciplinary team tackles the management of 84 uncommon cancers and blood disorders
Specialized clinic addresses long-term wellness through the study of somatic mutations
Common cancer therapy increases serious risks in murine models
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Treatment may be a lifesaving option for patients with relapsed or refractory disease
Study suggests new approach is safer than standard treatment and may help prevent graft-versus-host disease
Understudied Src Family Kinase may serve as a potential therapeutic target
Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination
Modification of traditional staging factors associated with survival in high-risk disease
Virtual clinic supports oncologists by educating patients and making treatment recommendations
Advertisement
Advertisement